Spiramycin
- Generic Name
- Spiramycin
- Brand Names
- Rovamycin
- Drug Type
- Small Molecule
- Chemical Formula
- C43H74N2O14
- CAS Number
- 24916-50-5
- Unique Ingredient Identifier
- 033ECH6IFG
- Background
Spiramycin is a primarily bacteriostatic macrolide antimicrobial agent with activity against Gram-positive cocci and rods, Gram-negative cocci and also Legionellae, mycoplasmas, chlamydiae, some types of spirochetes, Toxoplasma gondii and Cryptosporidium.
...
- Indication
Macrolide antibiotic for treatment of various infections.
- Associated Conditions
- Bacterial Infections
- Associated Therapies
- -
Open-Label "Compassionate" Use Study of Spiramycin for the Treatment of Diarrhea Due to Chronic Cryptosporidiosis in Immunocompromised Patients
- Conditions
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Rhone-Poulenc Rorer
- Registration Number
- NCT00002062
- Locations
- 🇺🇸
Rhone - Poulenc Rorer Pharmaceuticals, Horsham, Pennsylvania, United States
A Study of Spiramycin in the Treatment of Patients With AIDS-Related Diarrhea
- Conditions
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Rhone-Poulenc Rorer
- Target Recruit Count
- 25
- Registration Number
- NCT00000980
- Locations
- 🇺🇸
Univ Hosp of Cleveland / Case Western Reserve Univ, Cleveland, Ohio, United States
🇺🇸Nelson Tebedo Community Clinic, Dallas, Texas, United States
🇺🇸Kaiser Permanente Med Ctr, San Diego, California, United States
Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis
- Conditions
- Interventions
- First Posted Date
- 1999-10-19
- Last Posted Date
- 2009-05-14
- Target Recruit Count
- 600
- Registration Number
- NCT00004317
- Locations
- 🇺🇸
University of Chicago, Chicago, Illinois, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.